AKT1 and neoplasm: Additionally, the tumor stem cell population exhibits activation of the RAS/RAF/MEK/ERK, PI3K, AKT, and mTOR survival signaling pathways that provide growth advantage to the cancer-initiating stem cell population [14,15].